Start the conversation
Tesla Motors Inc. (Nasdaq: TSLA) stock hit a new high on Aug. 29 thanks to very positive news out of China.
The world leader in electric vehicles is set to install 400 charging stations in roughly 120 Chinese cities. And that's on top of 200 charging stations Tesla already operates in the world's most populous nation.
The news comes just weeks after Tesla began selling its luxurious $70,000 Model S in China.
So far this year, TSLA shares are up more than 80%. And its Chinese expansion should propel the stock even further – in fact, I think China will become Tesla's biggest market within the next year.
But that performance, as impressive as it is, pales in comparison to the performance of a Chinese auto e-commerce company I told you about on Feb. 4.
Since then, your shares have gone on a tear, rising some 220%.
This exciting stock isn't done yet, however, and I think you're going to make another 50% over the next couple of years. Let's see how that's going to happen…
A Very Speedy Auto Rally
My good friend and colleague Money Morning Executive Editor Bill Patalon and I have many things in common, not the least of which is we're both "car guys."
I used to be an auto analyst in Detroit, and I've rebuilt a couple of cars and worked on a dozen more. And Bill loves to regale me with stories of how he is working on his "little hot rod" – a 1931 Ford Model A Roadster Pickup with a beefed-up, small-block V8.
Naturally, then, when he suggested doing a Q&A with me last February about my views on China's burgeoning new-car market, I jumped at the chance.
At the time, I was convinced Bitauto Holdings Ltd. (NYSE ADR: BITA), which offers e-commerce and marketing services to China's auto market, offered savvy tech investors the chance for massive gains in relatively short order. Here's how I described Bitauto to Bill:
Talk about a growth machine. It has a three-year sales growth rate of 54% and has grown earnings per share in excess of 60% over the past three years.
If it just had half that earnings growth, profits per share would double in less than three years. In fact, I think the stock could double well before that if everything plays out the way I believe it will.
To put it mildly, the stock greatly exceeded my optimistic projections – again, a 220% pop in about seven months.
However, when a stock goes on such a quick, impressive rally, many investors wonder how much upside is left. (I'm betting that includes many of you who didn't invest in Bitauto the first or second time I recommended it.)
In this case, I still see potential for strong gains – and here's why.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.